This Million Targets Drug: A $7M Bet on a CNS Breakthrough
A focused look at a $7 million wager on a CNS drug maker in Phase 3. Learn what this move signals about biotech momen...
Index funds offer broad diversification with low fees, making them a solid foundation for retirement portfolios. This guide outlines how to choose and allocate them.
25,366 articlesA focused look at a $7 million wager on a CNS drug maker in Phase 3. Learn what this move signals about biotech momen...
A biotech stock that surged 135% in a year suddenly sees a big investor trim its stake by about $44 million. Here’s h...
If you want to trim your monthly costs without a dramatic lifestyle change, you’re not alone. This guide shows practi...
XRP trades in a narrow range as three big headwinds keep gains at bay. Analysts flag Bitcoin correlation, whale selli...
As 2026 unfolds, lenders tighten credit norms while demand for housing eases. The median approved borrower's credit s...
Santa Clara County filed a landmark lawsuit against Meta, accusing the company of profiting from scam advertisements ...
A late-breaking disclosure shows substantial purchases in Boeing and Nvidia by Donald Trump, as markets brace for a h...
A community college welding student is poised to represent the United States at WorldSkills, highlighting how afforda...
David Tepper's Appaloosa Management has loaded up on Micron as memory markets rebound, while bets on AMZN and UBER re...
Cardano confronts a pivotal treasury vote with Input Output seeking 46.8M ADA for 2026. cardano founder warns network...
Perceptic, a London-founded startup formed by former Palantir Life Sciences executives, launches from stealth with a ...
Bitcoin led a broad weekly retreat as ETF withdrawals and macro concerns trimmed appetite for risk, with altcoins fol...